Bioinformatics Production Small Molecule 
Drug Target Review
MARCH 28, 2024
Between 2000 and 2020, approximately 30 percent of the newly introduced small molecule drugs were derived from natural products. Why focus on natural products and phytochemicals? 3 This indicates there is a large pool of undiscovered natural products with therapeutic promise waiting to be mined.
Drug Target Review
JULY 12, 2023
Once a new drug target is identified, a proprietary deep learning artificial intelligence (AI) platform we call Fluency can rapidly identify small molecules that selectively bind to a target of interest. We are pleased that to date our lead product candidate has aligned DCI profiles as expected.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Nvidia Developer: Drug Discovery
DECEMBER 19, 2023
This data advantage enables their AI and product teams to outperform SoTA annotation and design models, addressing complex design challenges in biotech industries, from gene-writing therapeutics to plastic degradation. For more information, see the NVIDIA BioNeMo product page.
Dark Matter Blog
AUGUST 31, 2020
The majority of small molecule drugs induce their therapeutic effects by seeking out and binding to their intended target while avoiding most other molecules in the dense milieu of the cell interior. Our overall mission at Arrakis is to expand the set of “druggable” targets for small-molecule medicines to include RNA.
Practical Cheminformatics
JANUARY 8, 2024
It would be far more productive to privately or publicly fund an effort to generate large, relevant datasets and make the data publicly accessible. In each example, the authors use a modified version of their open source package MolPAL to design molecules with a specified selectivity profile.
Drug Target Review
SEPTEMBER 26, 2024
Cresset delivers software solutions and contract research expertise enabling companies around the world to accelerate their small molecule discovery processes efficiently and effectively. We are currently integrating our products with generative chemistry and AI chatbots. AI is a very fastmoving, evolving field.
Codon
AUGUST 27, 2024
Extra pieces of data, including proteins, lipids, or small molecules, are helpful when a particular DNA sequence is difficult to amplify or isolate from a sample, or when sequencing results don’t point squarely at a single disease-causing organism. But DNA alone is not always enough to identify a pathogen.
Expert insights. Personalized for you.
128 
Let's personalize your content